BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23125009)

  • 1. Significance of cyclin D1 polymorphisms in patients with head and neck cancer.
    Sabir M; Baig RM; Mahjabeen I; Kayani MA
    Int J Biol Markers; 2013 Apr; 28(1):49-55. PubMed ID: 23125009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.
    Zheng Y; Shen H; Sturgis EM; Wang LE; Eicher SA; Strom SS; Frazier ML; Spitz MR; Wei Q
    Carcinogenesis; 2001 Aug; 22(8):1195-9. PubMed ID: 11470749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cyclin D1 variants with head and neck cancer susceptibility: evidence from a meta-analysis.
    Lin H; Fang L; Lin D
    Asian Pac J Cancer Prev; 2014; 15(14):5645-51. PubMed ID: 25081680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between
    Thakur N; Kumari S; Mehrotra R
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
    [No Abstract]   [Full Text] [Related]  

  • 5. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
    Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
    Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients.
    Hsia TC; Liu CJ; Lin CH; Chang WS; Chu CC; Hang LW; Lee HZ; Lo WC; Bau DT
    Anticancer Res; 2011 Oct; 31(10):3601-5. PubMed ID: 21965784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population.
    Qiuling S; Yuxin Z; Suhua Z; Cheng X; Shuguang L; Fengsheng H
    Carcinogenesis; 2003 Sep; 24(9):1499-503. PubMed ID: 12807740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis.
    Tang C; Wang Z; Yu J; Wu Y; Zhu Z; Chen N
    Med Oncol; 2011 Dec; 28(4):1319-24. PubMed ID: 20443083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx.
    Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K
    Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rb1/105 gene alterations and head and neck carcinogenesis.
    Sabir M; Baig RM; Mahjabeen I; Saeed M; Malik FA; Kayani MA
    Mol Biol Rep; 2012 Oct; 39(10):9573-81. PubMed ID: 22744425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract.
    Buch S; Zhu B; Davis AG; Odom D; Siegfried JM; Grandis JR; Romkes M
    Mol Carcinog; 2005 Apr; 42(4):222-8. PubMed ID: 15754315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population.
    Khlifi R; Kallel I; Hammami B; Hamza-Chaffai A; Rebai A
    J Oral Pathol Med; 2014 Mar; 43(3):217-24. PubMed ID: 24020925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk.
    Shih LC; Tsai CW; Tsai MH; Tsou YA; Chang WS; Li FJ; Lee MH; Bau DT
    Anticancer Res; 2012 Mar; 32(3):1093-8. PubMed ID: 22399638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population.
    Sobti RC; Kaur P; Kaur S; Singh J; Janmeja AK; Jindal SK; Kishan J; Raimondi S
    Cancer Genet Cytogenet; 2006 Oct; 170(2):108-14. PubMed ID: 17011980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
    Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
    Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions.
    Huang M; Spitz MR; Gu J; Lee JJ; Lin J; Lippman SM; Wu X
    Carcinogenesis; 2006 Oct; 27(10):2034-7. PubMed ID: 16638786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
    Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of RAD 51 135 G/C, 172 G/T and XRCC3 Thr241Met gene polymorphisms with increased risk of head and neck cancer.
    Kayani MA; Khan S; Baig RM; Mahjabeen I
    Asian Pac J Cancer Prev; 2014; 15(23):10457-62. PubMed ID: 25556492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 polymorphism and the risk of endometrial cancer.
    Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.